Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 18:41 | 2025-10-31 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $18.72 | 106,850 | $1,999,998 | 20,398,784 | +0.5% |
| 2025-11-04 18:49 | 2025-10-31 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $18.72 | 587,672 | $10,999,991 | 43,230,340 | +1.4% |
| 2025-11-04 18:59 | 2025-10-31 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $18.72 | 480,823 | $8,999,992 | 50,010,551 | +1.0% |
| 2025-11-04 19:09 | 2025-10-31 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $16.33 | 244,986 | $4,000,012 | 14,799,227 | +1.7% |
| 2025-11-04 19:17 | 2025-10-31 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $16.33 | 673,712 | $11,000,032 | 19,774,389 | +3.5% |
| 2025-11-05 00:27 | 2025-11-03 | ASA | ASA Gold and Precious Metals Limited | Saba Capital Management, L.P. | 10% owner | Other | BUY | $46.21 | 26,152 | $1,208,484 | 5,145,514 | +0.5% |
| 2025-11-04 03:20 | 2025-10-31 | CLVT | CLARIVATE PLC | Cornick Kenneth L. | Director | Services-Computer Processing & Data Preparation | BUY | $3.42 | 725,000 | $2,481,965 | 1,000,000 | +263.6% |
| 2025-11-04 01:01 | 2025-11-01 | LNPIX | N/A | Partners Group (USA) Inc. | Other | Other | BUY | $10.25 | 487,805 | $5,000,000 | 0 | +100.0% |
| 2025-11-04 01:16 | 2025-10-31 | CLVT | CLARIVATE PLC | Snyder Andrew Miles | Director | Services-Computer Processing & Data Preparation | BUY | $3.33 | 1,460,000 | $4,861,800 | 2,247,510 | +185.4% |
| 2025-11-04 01:25 | 2025-05-14 | ORGO | Organogenesis Holdings Inc. | NUSSDORF GLENN H | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.06 | 358,495 | $1,096,027 | 358,495 | +100.0% |
| 2025-11-04 03:24 | 2025-10-30 | MSM | MSC INDUSTRIAL DIRECT CO INC | JACOBSON MITCHELL | Director, 10% owner | Wholesale-Industrial Machinery & Equipment | BUY | $84.75 | 181,806 | $15,408,440 | 2,305,322 | +8.6% |
| 2025-10-31 18:36 | 2025-10-30 | AMRZ | Amrize Ltd | Jenisch Jan Philipp | Director, Officer - Chairman & CEO | Cement, Hydraulic | BUY | $52.76 | 110,000 | $5,803,600 | 505,000 | +27.8% |
| 2025-11-01 00:26 | 2025-10-29 | BX | Blackstone Inc. | BREYER JAMES | Director | Investment Advice | BUY | $151.23 | 13,170 | $1,991,699 | 55,006 | +31.5% |
| 2025-10-31 16:46 | 2025-10-30 | AVTR | Avantor, Inc. | SUMME GREGORY L | Director | Laboratory Analytical Instruments | BUY | $11.25 | 100,000 | $1,125,000 | 300,000 | +50.0% |
| 2025-10-31 23:06 | 2025-10-30 | N/A | N/A | Equitable Holdings, Inc. | 10% owner, Other | Other | BUY | $38.81 | 75,000 | $2,910,728 | 81,520,154 | +0.1% |
| 2025-10-31 00:13 | 2025-10-28 | CGEM | Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $8.40 | 165,667 | $1,391,686 | 8,963,500 | +1.9% |
| 2025-10-30 21:33 | 2025-10-28 | N/A | N/A | Neuberger Berman Group LLC | 10% owner, Other | Other | BUY | $10.24 | 195,313 | $2,000,000 | 7,286,427 | +2.8% |
| 2025-10-31 03:39 | 2025-10-30 | BAH | Booz Allen Hamilton Holding Corp | ROZANSKI HORACIO | Director, Officer - President and CEO | Services-Management Consulting Services | BUY | $84.66 | 23,800 | $2,014,908 | 687,745 | +3.6% |
| 2025-10-30 23:31 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 952,941 | $16,199,997 | 3,686,622 | +34.9% |
| 2025-10-30 23:00 | 2025-10-29 | EG | EVEREST GROUP, LTD. | GALTNEY WILLIAM F JR | Director | Fire, Marine & Casualty Insurance | BUY | $307.38 | 11,385 | $3,499,521 | 45,491 | +33.4% |
| 2025-10-30 23:37 | 2025-10-30 | CLS | CELESTICA INC | KOELLNER LAURETTE T | Director | Printed Circuit Boards | BUY | $341.67 | 6,000 | $2,050,025 | 6,000 | +100.0% |
| 2025-10-29 23:16 | 2025-10-28 | MLPT | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 5,441,176 | $92,499,992 | 19,697,464 | +38.2% |
| 2025-10-30 02:22 | 2025-10-27 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $2.61 | 1,915,700 | $4,999,977 | 6,046,907 | +46.4% |
| 2025-10-30 02:19 | 2025-10-27 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners X, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $2.61 | 1,915,700 | $4,999,977 | 6,046,907 | +46.4% |
| 2025-10-30 01:03 | 2025-10-28 | PAYIX | N/A | Eliasek M Grier | Director, Officer - Chief Executive Officer | Other | BUY | $25.35 | 55,227 | $1,400,000 | 148,033 | +59.5% |
| 2025-10-30 02:21 | 2025-10-27 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $2.61 | 1,915,700 | $4,999,977 | 6,046,907 | +46.4% |
| 2025-10-29 02:40 | 2025-10-24 | RYES | Rise Gold Corp. | Equinox Partners Investment Management LLC | 10% owner | Metal Mining | BUY | $0.25 | 5,600,000 | $1,400,000 | 1,698,474 | +100.0% |
| 2025-10-28 23:27 | 2025-10-21 | PAYIX | N/A | Eliasek M Grier | Director, Officer - Chief Executive Officer | Other | BUY | $25.32 | 92,807 | $2,350,002 | 92,807 | +100.0% |
| 2025-10-28 16:00 | 2025-10-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Director, 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $1.62 | 3,703,703 | $5,999,999 | 21,350,815 | +21.0% |
| 2025-10-28 20:23 | 2025-10-27 | ASA | ASA Gold and Precious Metals Limited | Saba Capital Management, L.P. | 10% owner | Other | BUY | $44.08 | 28,500 | $1,256,280 | 5,079,840 | +0.6% |
| 2025-10-29 01:28 | 2025-10-27 | KMI | KINDER MORGAN, INC. | KINDER RICHARD D | Director, Officer, 10% owner - Executive Chairman | Natural Gas Transmission | BUY | $25.96 | 1,000,000 | $25,964,900 | 246,212,353 | +0.4% |
| 2025-10-27 14:29 | 2025-10-24 | FCN | FTI CONSULTING, INC | Gunby Steven Henry | Director, Officer - CEO, Chairman and President | Services-Management Consulting Services | BUY | $151.12 | 7,500 | $1,133,400 | 294,007 | +2.6% |
| 2025-10-27 23:30 | 2025-10-23 | VRDN | Viridian Therapeutics, Inc.\DE | Fairmount Funds Management LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $22.00 | 454,545 | $9,999,990 | 3,914,458 | +13.1% |
| 2025-10-28 01:54 | 2025-10-23 | ASA | ASA Gold and Precious Metals Limited | Saba Capital Management, L.P. | 10% owner | Other | BUY | $46.09 | 41,507 | $1,912,871 | 5,051,340 | +0.8% |
| 2025-10-28 02:24 | 2025-10-23 | RANI | Rani Therapeutics Holdings, Inc. | IMRAN MIR A | Director, 10% owner | Pharmaceutical Preparations | BUY | $0.61 | 2,083,334 | $1,260,417 | 2,083,334 | +100.0% |
| 2025-10-28 03:34 | 2025-10-01 | N-A | N/A | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 10% owner | Other | BUY | $14.17 | 534,634 | $7,575,758 | 5,539,544 | +10.7% |
| 2025-10-24 18:59 | 2025-10-22 | N/A | N/A | Abu Dhabi Investment Authority | 10% owner | Other | BUY | $1,789.25 | 18,164 | $32,500,000 | 115,771 | +18.6% |
| 2025-10-24 18:58 | 2025-10-22 | N/A | N/A | Abu Dhabi Investment Authority | 10% owner | Other | BUY | $14.44 | 5,540,093 | $80,000,055 | 25,046,253 | +28.4% |
| 2025-10-24 04:06 | 2025-10-21 | SMMT | Summit Therapeutics Inc. | Xia Yu | Director | Pharmaceutical Preparations | BUY | $18.74 | 533,617 | $9,999,983 | 32,057,147 | +1.7% |
| 2025-10-23 19:20 | 2025-10-21 | ASA | ASA Gold and Precious Metals Limited | Saba Capital Management, L.P. | 10% owner | Other | BUY | $45.00 | 45,090 | $2,029,235 | 5,009,833 | +0.9% |
| 2025-10-24 02:49 | 2025-10-21 | NEUP | Neuphoria Therapeutics Inc. | Lynx1 Capital Management LP | 10% owner | Pharmaceutical Preparations | BUY | $5.14 | 639,110 | $3,283,108 | 875,328 | +270.6% |
| 2025-10-23 23:18 | 2025-10-21 | N/A | Copper Property CTL Pass Through Trust | Silver Point Capital L.P. | 10% owner | Real Estate | BUY | $12.13 | 541,256 | $6,566,031 | 9,664,039 | +5.9% |
| 2025-10-22 23:34 | 2025-10-20 | N/A | N/A | Lewinsohn Jonathan | Director | Other | BUY | $27.39 | 51,749 | $1,417,497 | 271,428 | +23.6% |
| 2025-10-23 04:30 | 2025-10-20 | N/A | N/A | Apollo Principal Holdings B, L.P. | 10% owner | Other | BUY | $27.39 | 894,433 | $24,499,956 | 9,441,812 | +10.5% |
| 2025-10-22 21:19 | 2025-10-22 | NUGN | Livento Group, Inc. | Henriksen Michael Gregory Max | Officer, 10% owner - Chief Investment Officer | Services-Prepackaged Software | BUY | $0.00 | 2,000,000,000 | $4,000,000 | 3,083,040,806 | +184.7% |
| 2025-10-22 21:05 | 2025-10-20 | N/A | N/A | Neuberger Berman Group LLC | 10% owner, Other | Other | BUY | $10.20 | 98,039 | $1,000,000 | 7,091,114 | +1.4% |
| 2025-10-23 00:13 | 2025-10-20 | CNS | COHEN & STEERS, INC. | STEERS ROBERT HAMILTON | Director, Officer, 10% owner - Executive Chairman | Investment Advice | BUY | $70.21 | 40,539 | $2,846,316 | 3,858,709 | +1.1% |
| 2025-10-22 02:00 | 2025-10-14 | CGEM | Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $8.46 | 248,749 | $2,103,919 | 8,797,833 | +2.9% |
| 2025-10-22 00:46 | 2025-10-21 | N/A | N/A | BCRED X HOLDINGS LLC | 10% owner | Other | BUY | $25.77 | 9,313,155 | $240,000,000 | 4,820,515 | +100.0% |
| 2025-10-21 23:47 | 2025-10-20 | CSX | CSX CORP | ANGEL STEPHEN F | Director, Officer - President & CEO | Railroads, Line-Haul Operating | BUY | $36.87 | 55,000 | $2,027,850 | 58,234 | +1,700.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.